Retention of patients in opioid substitution treatment: a systematic review

AM O'Connor, G Cousins, L Durand, J Barry, F Boland - PloS one, 2020 - journals.plos.org
Background Retention in opioid substitution (OST) treatment is associated with substantial
reductions in all cause and overdose mortality. This systematic review aims to identify both …

[HTML][HTML] Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research

FR Mendes, C dos Santos Costa, VD Wiltenburg… - Addiction …, 2022 - Elsevier
Substance use disorder (SUD) is a global public health concern that affects millions of
people worldwide. Considering current research, addiction has been noted as the last stage …

Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional …

P Lucas, EP Baron, N Jikomes - Harm reduction journal, 2019 - Springer
Background A 239-question cross-sectional survey was sent out via email in January 2017
to gather comprehensive information on cannabis use from Canadian medical cannabis …

The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada

M Piske, H Zhou, JE Min, N Hongdilokkul… - …, 2020 - Wiley Online Library
Abstract Background and Aims The 'cascade of care'framework, measuring attrition at
various stages of care engagement, has been proposed to guide the public health response …

Cannabis significantly reduces the use of prescription opioids and improves quality of life in authorized patients: results of a large prospective study

P Lucas, S Boyd, MJ Milloy, Z Walsh - Pain Medicine, 2021 - academic.oup.com
Objectives This article presents findings from a large prospective examination of Canadian
medical cannabis patients, with a focus on the impacts of cannabis on prescription opioid …

Trajectories of retention in opioid agonist therapy in a Canadian setting

ME Socías, H Dong, E Wood, R Brar… - International Journal of …, 2020 - Elsevier
Background Long-term engagement in opioid agonist therapy (OAT) has been consistently
associated with reduced risk for morbidity and mortality in people with opioid use disorder …

“I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums

MC Meacham, AL Nobles, DA Tompkins, J Thrul - PloS one, 2022 - journals.plos.org
A growing body of research has reported on the potential opioid-sparing effects of cannabis
and cannabinoids, but less is known about specific mechanisms. The present research …

The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study

C Bharat, S Larney, S Barbieri, T Dobbins… - …, 2021 - Wiley Online Library
Abstract Background and Aims There is limited evidence on the relationship between
retention in opioid agonist treatment for opioid dependence and characteristics of treatment …

The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review

S Lake, MS Pierre - Clinical Psychology Review, 2020 - Elsevier
Despite high rates of cannabis use during medication-based treatment of opioid use
disorder (MOUD), uncertainty remains around how cannabis influences treatment outcomes …

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

C Lee, M Lin, KJB Martins, JRB Dyck, S Klarenbach… - BMC Public Health, 2021 - Springer
Background The opioid overdose epidemic in Canada and the United States has become a
public health crisis-with exponential increases in opioid-related morbidity and mortality …